BioCentury
ARTICLE | Company News

CuraGen board of directors update

June 27, 2005 7:00 AM UTC

CuraGen Corp. (CRGN), New Haven, Conn. Business: Cancer, Inflammation, Endocrine Appointed: Michael Astrue, former president and CEO of Transkaryotic Therapies Inc.; and Frank Armstrong, CEO of Bioacc...